PET-enabled Dual-energy CT for Oncological Applications
This pilot study, sponsored by the University of California, Davis, aims to evaluate a novel imaging technique that combines PET and dual-energy CT to enhance the assessment of bone marrow composition in multiple myeloma patients undergoing CAR T-cell therapy. The potential commercial implications are significant, as advancements in imaging technologies can lead to improved diagnostic capabilities and treatment monitoring in oncology. The study's findings may position UC Davis as a leader in innovative imaging methodologies, attracting partnerships with pharmaceutical companies and imaging device manufacturers. Given the increasing prevalence of multiple myeloma and the growing market for CAR T-cell therapies, successful validation of this imaging method could open avenues for further research funding and commercialization opportunities in the oncology imaging sector.
Indication: Multiple Myeloma (MM)
Modality: cell therapy
Target: PET-enabled dual-energy CT for measuring bone and soft-tissue composition in bone marrow.
Sponsor: University of California, Davis
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 03, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: PET-enabled dual-energy CT for measuring bone and soft-tissue composition in bone marrow.
View original source fields
Condition raw: Multiple Myeloma (MM)
Condition normalized: Multiple Myeloma (MM)
Modality raw: cell therapy
Modality normalized: cell therapy
Target raw: PET-enabled dual-energy CT for measuring bone and soft-tissue composition in bone marrow.
Target normalized: PET-enabled dual-energy CT for measuring bone and soft-tissue composition in bone marrow.